Deniz Gezer

1.2k total citations
22 papers, 312 citations indexed

About

Deniz Gezer is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Deniz Gezer has authored 22 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 13 papers in Genetics and 8 papers in Molecular Biology. Recurrent topics in Deniz Gezer's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Acute Myeloid Leukemia Research (9 papers) and Eosinophilic Disorders and Syndromes (5 papers). Deniz Gezer is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Acute Myeloid Leukemia Research (9 papers) and Eosinophilic Disorders and Syndromes (5 papers). Deniz Gezer collaborates with scholars based in Germany, United Kingdom and United States. Deniz Gezer's co-authors include Kamil R. Kranc, Milica Vukovic, Patrick J. Pollard, Tessa L. Holyoake, Chithra Subramani, Alejandro Armesilla-Diaz, Peter J. Ratcliffe, Amélie V. Guitart, Steffen Koschmieder and Tim H. Brümmendorf and has published in prestigious journals such as Blood, Stem Cells and Cancer Letters.

In The Last Decade

Deniz Gezer

19 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deniz Gezer Germany 9 182 154 106 68 40 22 312
Eva Lumbreras Spain 10 146 0.8× 138 0.9× 42 0.4× 62 0.9× 26 0.7× 23 306
Aliaksandra Maroz Germany 5 292 1.6× 156 1.0× 205 1.9× 38 0.6× 34 0.8× 7 438
Marta Jeison Israel 13 178 1.0× 127 0.8× 101 1.0× 34 0.5× 18 0.5× 20 345
Yajuan Cui China 10 186 1.0× 119 0.8× 49 0.5× 95 1.4× 26 0.7× 25 356
Stefanie Herkt Germany 7 135 0.7× 94 0.6× 40 0.4× 38 0.6× 25 0.6× 11 232
Simon Renders Germany 9 121 0.7× 126 0.8× 38 0.4× 44 0.6× 113 2.8× 17 295
Paula de Melo Campos Brazil 11 147 0.8× 168 1.1× 28 0.3× 83 1.2× 101 2.5× 43 353
Parimala Sonika Godavarthy Germany 8 95 0.5× 134 0.9× 38 0.4× 53 0.8× 61 1.5× 10 249
Siying Zou United States 8 134 0.7× 81 0.5× 57 0.5× 30 0.4× 43 1.1× 13 288
Edy Hasrouni United States 5 225 1.2× 264 1.7× 43 0.4× 108 1.6× 13 0.3× 17 374

Countries citing papers authored by Deniz Gezer

Since Specialization
Citations

This map shows the geographic impact of Deniz Gezer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deniz Gezer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deniz Gezer more than expected).

Fields of papers citing papers by Deniz Gezer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deniz Gezer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deniz Gezer. The network helps show where Deniz Gezer may publish in the future.

Co-authorship network of co-authors of Deniz Gezer

This figure shows the co-authorship network connecting the top 25 collaborators of Deniz Gezer. A scholar is included among the top collaborators of Deniz Gezer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deniz Gezer. Deniz Gezer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gezer, Deniz, Martin Kirschner, Tim H. Brümmendorf, et al.. (2024). Retrospective study on pomalidomide‐PACE as a salvage regimen in aggressive relapsed and refractory multiple myeloma. European Journal Of Haematology. 113(4). 465–471.
2.
Toledo, Marcelo A. S., Angela Maurer, Fabian Beier, et al.. (2023). P1008: THE TELOMERASE INHIBITOR IMETELSTAT DIFFERENTIALLY TARGETS JAK2V617F- VERSUS CALR-MUTANT MYELOPROLIFERATIVE NEOPLASM CELLS AND INHIBITS JAK-STAT SIGNALING. HemaSphere. 7(S3). e661233c–e661233c.
3.
Toledo, Marcelo A. S., Angela Maurer, Fabian Beier, et al.. (2023). The telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling. Frontiers in Oncology. 13. 1277453–1277453. 7 indexed citations
4.
Baumeister, Julian, Angela Maurer, Deniz Gezer, et al.. (2022). Clonogenic assays improve determination of variant allele frequency of driver mutations in myeloproliferative neoplasms. Annals of Hematology. 101(12). 2655–2663.
5.
Salimi, Azam, Mirle Schemionek, Margherita Vieri, et al.. (2022). Targeting autophagy increases the efficacy of proteasome inhibitor treatment in multiple myeloma by induction of apoptosis and activation of JNK. BMC Cancer. 22(1). 735–735. 19 indexed citations
6.
Baumeister, Julian, Tiago Maié, Nicolas Chatain, et al.. (2021). Early and late stage MPN patients show distinct gene expression profiles in CD34+ cells. Annals of Hematology. 100(12). 2943–2956. 8 indexed citations
7.
Elbracht, Miriam, Robert Meyer, Deniz Gezer, et al.. (2021). Germline variants in DNA repair genes, including BRCA1/2, may cause familial myeloproliferative neoplasms. Blood Advances. 5(17). 3373–3376. 8 indexed citations
8.
Han, Lijuan, Marcelo A. S. Toledo, Ivan G. Costa, et al.. (2021). CALR frameshift mutations in MPN patient-derived iPSCs accelerate maturation of megakaryocytes. Stem Cell Reports. 16(11). 2768–2783. 9 indexed citations
9.
Gezer, Deniz, et al.. (2020). Tolerability of high dose chemotherapy and autologous stem cell transplantation in elderly patients with multiple myeloma: A single-center retrospective analysis. Current Research in Translational Medicine. 68(3). 139–144. 3 indexed citations
10.
Baumeister, Julian, Nicolas Chatain, Tiago Maié, et al.. (2019). Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasms. Leukemia. 34(4). 1062–1074. 41 indexed citations
11.
Kirschner, Martin, Claudia Schubert, Deniz Gezer, et al.. (2019). Transcriptional alteration of DNA repair genes in Philadelphia chromosome negative myeloproliferative neoplasms. Annals of Hematology. 98(12). 2703–2709. 3 indexed citations
12.
Koschmieder, Steffen, Susanne Isfort, Dominik Wolf‎, et al.. (2019). Ruxolitinib Shows Efficacy in Patients with Newly-Diagnosed Polycythemia Vera: Futility Analysis of the Randomized Ruxo-BEAT Clinical Trial of the German Study Group for Myeloproliferative Neoplasms. Blood. 134(Supplement_1). 2944–2944. 4 indexed citations
13.
Gezer, Deniz, Oliver Herrmann, Mirle Schemionek, et al.. (2019). LCP1 triggers mTORC2/AKT activity and is pharmacologically targeted by enzastaurin in hypereosinophilia. Molecular Carcinogenesis. 59(1). 87–103. 11 indexed citations
14.
Gezer, Deniz, et al.. (2019). STAT1 Transcriptional Response Predicts Molecular Responses of PB-Derived Clonogenic Cells from MPN Patients to Interferon Alpha. Blood. 134(Supplement_1). 1679–1679. 1 indexed citations
15.
Isfort, Susanne, Martina Crysandt, Deniz Gezer, et al.. (2018). Bosutinib: A Potent Second-Generation Tyrosine Kinase Inhibitor. Recent results in cancer research. 212. 87–108. 9 indexed citations
16.
Vukovic, Milica, Chithra Subramani, Amélie V. Guitart, et al.. (2016). Adult hematopoietic stem cells lacking Hif-1α self-renew normally. Blood. 127(23). 2841–2846. 65 indexed citations
17.
Bruns, Heiko, Dimitrios Mougiakakos, Christian Bach, et al.. (2016). the IKZF1-IRF4 Axis Regulates Macrophage Polarization and Macrophage-Mediated Anti-Tumor Immunity. Blood. 128(22). 2514–2514. 2 indexed citations
18.
Gezer, Deniz, Milica Vukovic, Tomoyoshi Soga, Patrick J. Pollard, & Kamil R. Kranc. (2014). Concise Review: Genetic Dissection of Hypoxia Signaling Pathways in Normal and Leukemic Stem Cells. Stem Cells. 32(6). 1390–1397. 24 indexed citations
19.
Guitart, Amélie V., Chithra Subramani, Alejandro Armesilla-Diaz, et al.. (2013). Hif-2α is not essential for cell-autonomous hematopoietic stem cell maintenance. Blood. 122(10). 1741–1745. 64 indexed citations
20.
Jost, Edgar, Deniz Gezer, Stefan Wilop, et al.. (2009). Epigenetic dysregulation of secreted Frizzled-related proteins in multiple myeloma. Cancer Letters. 281(1). 24–31. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eva Lumbreras Breakdown of academic impact, for papers by Aliaksandra Maroz Breakdown of academic impact, for papers by Marta Jeison Breakdown of academic impact, for papers by Yajuan Cui Breakdown of academic impact, for papers by Stefanie Herkt Breakdown of academic impact, for papers by Simon Renders Breakdown of academic impact, for papers by Paula de Melo Campos Breakdown of academic impact, for papers by Parimala Sonika Godavarthy Breakdown of academic impact, for papers by Siying Zou Breakdown of academic impact, for papers by Edy Hasrouni
Rankless by CCL
2026